鐢�(ch菐n)鍝佸悕绋� | BCL2鍒嗗瓙浼翠径瑾�(di脿o)绡€(ji茅)铔嬬櫧5鎶楅珨 |
鑻辨枃鍚嶇ū | Anti-BAG5 |
瑕�(gu墨)鏍� | 0.2ml/200渭g |
婵冨害 | 1mg/1ml |
鍍�(ji脿)鏍� | 渚嗛浕鍙韩鍙楀劒(y艒u)鎯� |
鑻辨枃鍚嶇ū Anti-BAG5
涓枃鍚嶇ū BCL2鍒嗗瓙浼翠径瑾�(di脿o)绡€(ji茅)铔嬬櫧5鎶楅珨
婵� 搴� 1mg/1ml
瑕�(gu墨) 鏍� 0.2ml/200渭g
鎶楅珨渚嗘簮 Rabbit
鍏嬮殕椤炲瀷 polyclonal
浜ゅ弶鍙嶆噳(y墨ng) Human, Mouse, Rat, Chicken, Dog
鐢�(ch菐n)鍝侀鍨� 涓€鎶�
鐮旂┒闋�(l菒ng)鍩� 鑵槫 绱�(x矛)鑳炵敓鐗� 鍏嶇柅瀛�(xu茅) 绱�(x矛)鑳炲噵浜�
铔嬬櫧鍒嗗瓙閲� predicted molecular weight: 51kDa
鎬� 鐙€ Lyophilized or Liquid
鍏� 鐤� 鍘� KLH conjugated synthetic peptide derived from humanBAG5
浜� 鍨� IgG
绱斿寲鏂规硶 affinity purified by Protein A
鍎�(ch菙) 瀛� 娑� 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide
鐢�(ch菐n)鍝佹噳(y墨ng)鐢� WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
锛堢煶锠熷垏鐗囬渶鍋氭姉鍘熶慨寰�(f霉)锛�
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
淇濆瓨姊濅欢 Store at -46 掳C for oneyear.
鍒� 鍚� BAG family molecular chaperone regulator 5; BAG 5;BAG-5; BCL2 associated athanogene 5; KIAA0873; BAG5_HUMAN.
